What is radiopharmaceutical therapy and how does it work?

Radiopharmaceutical therapy (RPT) uses targeted radioactive drugs, called radioligands, that bind to specific cancer cells to both diagnose disease through imaging and treat tumors with precision radiation.

What is theranostics in oncology?

Theranostics is the pairing of diagnostic imaging and radiopharmaceutical therapy, where the same molecular target is used to first detect tumors and then deliver targeted radiation for treatment.

How does Perceptive support radiopharmaceutical therapy development?

Perceptive has supported over 80 radioligand therapy clinical trials and hundreds of preclinical studies by providing radiochemistry, imaging, dosimetry, and regulatory expertise to accelerate clinical development.

What therapeutic areas are targeted by radiopharmaceuticals?

Radiopharmaceutical therapies are commonly used in cancers such as metastatic castration-resistant prostate cancer with PSMA-targeted agents, and new targets like fibroblast activation protein (FAP) are also being developed.

What imaging capabilities support radiopharmaceutical clinical trials?

Perceptive operates in-house imaging centers in London and New Haven equipped with GMP radiochemistry, PET/CT, PET/MR, 3T MRI, and SPECT to deliver high-quality imaging for radiopharmaceutical studies.

Is Imaging Putting Your Ongoing Study at Risk?

Get your study back on track with Perceptive Imaging Rescue Support

Request an Imaging Rescue Assessment

Home

Clinical Trial Imaging Challenges

Regain Confidence in Your Study’s Imaging

Whether your study’s imaging is more complex than anticipated, or you’re losing confidence in your current imaging provider, our experts can quickly assess the situation and recommend an imaging recovery plan to help you get your study back on track.

If you find yourself in this situation, you aren’t looking for another vendor. You’re looking for a trusted partner with experience, expertise, and operational discipline to manage the complexity of the transition and restore confidence in your imaging strategy.

Perceptive is that partner. We’ve helped many sponsors rescue the imaging components of their studies, recover lost ground, and move forward with confidence.

Is Your Study’s Imaging in Need of Rescue Support?

If you’re noticing any of the following imaging issues, rescue support may be needed:

Data quality issues are creating concerns about endpoint integrity.

Site performance is inconsistent, which means that image quality and assessments may be unreliable.

Your study’s current imaging provider is struggling to meet key deliverable timelines.

Confidence in your current imaging strategy is declining.

Scientific guidance and regulatory expertise related to imaging are lacking.

Study teams are spending excessive time managing vendor issues.

Proven Success in Rescuing Clinical Trial Imaging

Perceptive is regularly engaged to help researchers rescue the imaging components of their studies. Whether you are a small biotech venturing into clinical trial imaging for the first time or one of the world’s leading global pharmaceutical companies, we can help you regain control of your trial’s imaging needs.

Learn how researchers have recovered their study momentum by stabilizing imaging through Perceptive’s rescue support:

Case Study: Rescuing a Study Facing Time and Data Quality Risks

When a leading academic research facility was unable to adequately support a complex cardiovascular study, the sponsor – a leading medical device company – faced growing concerns around timelines, site performance, and data quality that threatened study execution.

Perceptive stepped in to manage a seamless transition, establish imaging governance, improve site performance, implement robust quality controls, and standardize image acquisition and review processes. Leveraging extensive imaging rescue experience, our team quickly stabilized operations and delivered high-quality, reproducible data aligned with aggressive timelines and regulatory expectations.

Download Case Study

"*" indicates required fields

Company

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Job title*

Company name*

name@emailaddress.com*

By submitting this form, you agree to receive communications from Perceptive. In line with our Privacy Policy, we never sell your information, and you can unsubscribe at any time.

Case Study: Helping a Sponsor Navigate the Complexities of Multiple Myeloma Imaging

A mid-sized biotechnology company initially managed the imaging components of a Phase II multiple myeloma trial internally. As enrollment progressed, the team encountered significant complexities associated with imaging-based endpoint assessment, including modality standardization across more than 30 global sites, integration of imaging and laboratory data according to IMWG criteria, and the need for a regulatory-ready review process.

Perceptive Imaging was engaged to quickly establish compliant imaging workflows, harmonize image acquisition practices, and support accelerated timelines without disrupting the study. By providing scientific, operational, and review expertise, Perceptive helped transform a challenging imaging environment into a submission-ready program that ultimately supported FDA accelerated approval.

Download Case Study

"*" indicates required fields

Name

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Job title*

Company name*

name@emailaddress.com*

By submitting this form, you agree to receive communications from Perceptive. In line with our Privacy Policy, we never sell your information, and you can unsubscribe at any time.

Case Study: Helping a Sponsor Regain Confidence in Complex Rare Disease Imaging

A small biotech company developing novel rare disease therapies needed reliable imaging evidence to support critical eligibility, safety, and efficacy assessments. But after working with other imaging core labs, they realized that inconsistent image quality, unclear acquisition guidance, and gaps in scientific and operational oversight were putting their confidence in the study’s endpoints at risk.

Perceptive helped the sponsor regain control by simplifying imaging requirements, strengthening site qualification and quality oversight, rebuilding the independent review framework, and providing ongoing scientific and medical guidance. With the imaging strategy stabilized, the sponsor could move forward with confidence in the quality and reliability of the data supporting key study decisions.

Download Case Study

"*" indicates required fields

Phone

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Job title*

Company name*

name@emailaddress.com*

By submitting this form, you agree to receive communications from Perceptive. In line with our Privacy Policy, we never sell your information, and you can unsubscribe at any time.

Is Imaging Putting Your Ongoing Study at Risk?

Regain Confidence in Your Study’s Imaging

Is Your Study’s Imaging in Need of Rescue Support?

Proven Success in Rescuing Clinical Trial Imaging

Case Study: Rescuing a Study Facing Time and Data Quality Risks

Download Case Study

Case Study: Helping a Sponsor Navigate the Complexities of Multiple Myeloma Imaging

Download Case Study

Case Study: Helping a Sponsor Regain Confidence in Complex Rare Disease Imaging

Download Case Study

Stay Updated

Never miss a beat.